Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Winther-Larsen

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Thrombosis Research|December 11, 2019
Protein C deficiency; PROC gene variants in a Danish populationAnne Winther-Larsen, Alisa D Kjaergaard, Ole H Larsen, et al.
Clinical Chemistry and Laboratory Medicine|August 13, 2022
Short-term biological variation of serum glial fibrillary acidic proteinSilje Hovden Christensen, Claus Vinter Bødker Hviid, Anne Tranberg Madsen, et al.
Translational Oncology|November 7, 2016
Early Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC PatientsAnne Winther-Larsen, Joan Fledelius, Christina Demuth, et al.
Cancers|October 7, 2020
Neurofilament Light Chain as A Biomarker for Brain MetastasesAnne Winther-Larsen, Claus Vinter Bødker Hviid, Peter Meldgaard, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2015
Genetic polymorphism in the epidermal growth factor receptor gene predicts outcome in advanced non-small cell lung cancer patients treated with erlotinibAnne Winther-Larsen, Peter Henrik Nissen, Kristine Raaby Jakobsen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 19, 2026
Neutrophil activation parameter is a promising new biomarker of disease activity in ulcerative colitisAnne-Birgitte Garm Blavnsfeldt, Tina Parkner, Cindy Søndersø Knudsen, et al.
Clinical Chemistry and Laboratory Medicine|July 24, 2025
A step forward in pediatric hemophagocytic lymphohistiocytosis and autoimmune disease: pediatric reference interval for serum soluble IL-2 receptor and soluble CD163Victor Bruun, Tina Parkner, Anne Winther-Larsen, et al.
British Journal of Cancer|July 7, 2017
Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patientsAnne Winther-Larsen, Christina Demuth, Joan Fledelius, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patientsJohanne Andersen Hojbjerg, Eva Boysen Fynboe Ebert, Michelle Simone Clement, et al.
Journal of Pediatric Hematology/Oncology|November 27, 2023
Extreme Reticulocytosis After Splenectomy in a Patient With Hemoglobin MizuhoHelene Narvestad-Bøttger, Anne Winther-Larsen, Jens Haugbølle Bjerre, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Thrombosis Research|December 11, 2019
Protein C deficiency; PROC gene variants in a Danish populationAnne Winther-Larsen, Alisa D Kjaergaard, Ole H Larsen, et al.
Clinical Chemistry and Laboratory Medicine|August 13, 2022
Short-term biological variation of serum glial fibrillary acidic proteinSilje Hovden Christensen, Claus Vinter Bødker Hviid, Anne Tranberg Madsen, et al.
Translational Oncology|November 7, 2016
Early Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC PatientsAnne Winther-Larsen, Joan Fledelius, Christina Demuth, et al.
Cancers|October 7, 2020
Neurofilament Light Chain as A Biomarker for Brain MetastasesAnne Winther-Larsen, Claus Vinter Bødker Hviid, Peter Meldgaard, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2015
Genetic polymorphism in the epidermal growth factor receptor gene predicts outcome in advanced non-small cell lung cancer patients treated with erlotinibAnne Winther-Larsen, Peter Henrik Nissen, Kristine Raaby Jakobsen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 19, 2026
Neutrophil activation parameter is a promising new biomarker of disease activity in ulcerative colitisAnne-Birgitte Garm Blavnsfeldt, Tina Parkner, Cindy Søndersø Knudsen, et al.
Clinical Chemistry and Laboratory Medicine|July 24, 2025
A step forward in pediatric hemophagocytic lymphohistiocytosis and autoimmune disease: pediatric reference interval for serum soluble IL-2 receptor and soluble CD163Victor Bruun, Tina Parkner, Anne Winther-Larsen, et al.
British Journal of Cancer|July 7, 2017
Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patientsAnne Winther-Larsen, Christina Demuth, Joan Fledelius, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patientsJohanne Andersen Hojbjerg, Eva Boysen Fynboe Ebert, Michelle Simone Clement, et al.
Journal of Pediatric Hematology/Oncology|November 27, 2023
Extreme Reticulocytosis After Splenectomy in a Patient With Hemoglobin MizuhoHelene Narvestad-Bøttger, Anne Winther-Larsen, Jens Haugbølle Bjerre, et al.
Pageof 5